Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
HCC1937 | Buparlisib | pan PI3K | PI3K/mTOR | 1.4479 | -0.2256 | 0.2634 | 0.0691 | 1.0878 | 2.8639 | 0.99474 |
HCC1937 | Pictilisib | pan PI3K | PI3K/mTOR | 2.4235 | 0.2784 | 0.2110 | 0.0249 | 0.5947 | 2.7026 | 0.99034 |
HCC1937 | Ceritinib | ALK | RTK | 3.5257 | -0.5730 | 0.1368 | 0.0730 | 2.2956 | 5.6897 | 0.99584 |
HCC1937 | Neratinib | EGFR/HER2 | RTK | 1.4603 | 0.2999 | 0.1711 | 0.0289 | 0.5189 | 12.13 | 0.97447 |
HCC1937 | Tivantinib | MET | RTK | 0.64919 | -0.0621 | 0.2925 | 0.0799 | 2.1267 | 0.69626 | 0.99463 |
HCC1937 | Cediranib | VEGFR/cKIT | RTK | 7.9267 | 0.2784 | 0.0440 | 0.0316 | 3.5480 | 8.352 | 0.99376 |
HCC1937 | Cabozantinib | VEGFR2/MET | RTK | 14.4371 | 0.7602 | 0.0053 | 0.0067 | 4.9892 | 11.0339 | 0.95897 |
HCC1954 | Abemaciclib | CDK4/6 | Cell cycle | 0.30182 | -0.5049 | 0.4578 | 0.0869 | 0.4867 | 2.8851 | 0.937 |
HCC1954 | Palbociclib | CDK4/6 | Cell cycle | Inf | 0.5256 | 0.1839 | -0.0048 | 1.2148 | 0.056374 | 0.97285 |
HCC1954 | AZD7762 | CHK1/2 | Cell cycle | 0.12298 | -0.3978 | 0.5593 | 0.2944 | 1.4965 | 0.1737 | 0.98591 |
HCC1954 | Volasertib | PLK | Cell cycle | 0.0065835 | -0.1540 | 0.6139 | 0.2792 | 3.4968 | 0.0071308 | 0.99812 |
HCC1954 | Dinaciclib | pan CDK | Cell cycle | 0.012538 | -0.4640 | 0.6411 | 0.3049 | 3.3292 | 0.015238 | 0.99808 |
HCC1954 | Cisplatin | Chemo | Chemotherapy | 1.2467 | -0.0741 | 0.2747 | 0.0807 | 1.1281 | 1.7233 | 0.97383 |
HCC1954 | Doxorubicin | Chemo | Chemotherapy | 0.0071835 | -0.3378 | 0.7296 | 0.2544 | 1.4590 | 0.0086345 | 0.96869 |
HCC1954 | Taxol | Chemo | Chemotherapy | 0.0024667 | -0.3961 | 0.8347 | 0.4142 | 1.6514 | 0.0034177 | 0.98666 |
HCC1954 | Topotecan | Topo I | Chemotherapy | 0.011912 | -0.4011 | 0.8695 | 0.3601 | 0.7510 | 0.02452 | 0.96722 |
HCC1954 | Etoposide | Topo II | Chemotherapy | 0.17121 | -0.2651 | 0.5015 | 0.2166 | 0.9804 | 0.2578 | 0.98586 |
HCC1954 | Dasatinib | BCR/ABL | MAPK/nRTK | 1.9424 | 0.2744 | 0.2026 | 0.0810 | 0.7356 | 1.1887 | 0.97254 |
HCC1954 | Trametinib | MEK | MAPK/nRTK | 0.016729 | 0.2287 | 0.4005 | 0.0565 | 0.8524 | 0.0082359 | 0.9993 |
HCC1954 | Saracatinib | SRC | MAPK/nRTK | 2.1208 | 0.0936 | 0.1939 | 0.0551 | 0.7876 | 4.0749 | 0.98936 |
HCC1954 | ABT-737 | Bcl2/XL | Misc | 9.9512 | 0.4962 | 0.0404 | 0.0618 | 1.0240 | 27.9634 | 0.94601 |
HCC1954 | Vorinostat | HDAC | Misc | 1.426 | -0.1401 | 0.2339 | 0.0833 | 1.2390 | 2.0871 | 0.99732 |
HCC1954 | Luminespib | HSP90 | Misc | 0.010331 | -0.3745 | 0.6188 | 0.2958 | 2.6936 | 0.012628 | 0.99618 |
HCC1954 | A-1210477 | Mcl-1 | Misc | Inf | 0.8844 | -0.0259 | 0.0076 | 0.0000 | Inf | 0.43063 |
HCC1954 | Olaparib | PARP | Misc | 11.1008 | 0.5266 | 0.0536 | 0.0095 | 1.2000 | 8.359 | 0.96291 |